{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:59:59Z","timestamp":1792605599074,"version":"4.5.0"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00198-022-06462-3","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T06:03:51Z","timestamp":1656050631000},"page":"2259-2274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Management of osteoporosis in patients with chronic kidney disease"],"prefix":"10.1007","volume":"33","author":[{"given":"M.","family":"Abdalbary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sobh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Elnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Elhadedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Elshabrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4484-1971","authenticated-orcid":false,"given":"K.","family":"Asadipooya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Halawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"El-Husseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"6462_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","volume":"94","author":"WHO","year":"1993","unstructured":"WHO (1993) Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 94:646\u2013650","journal-title":"Am J Med"},{"key":"6462_CR2","first-page":"1","volume":"843","author":"WHO","year":"1994","unstructured":"WHO (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1\u2013129","journal-title":"World Health Organ Tech Rep Ser"},{"key":"6462_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH","year":"2001","unstructured":"NIH (2001) Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. JAMA 285:785\u2013795","journal-title":"JAMA"},{"key":"6462_CR4","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s00198-021-05975-7","volume":"32","author":"P Evenepoel","year":"2021","unstructured":"Evenepoel P, Cunningham J, Ferrari S, Haarhaus M, Javaid MK, Lafage-Proust MH, Prieto-Alhambra D, Torres PU, Cannata-Andia J (2021) Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism. Osteoporos Int 32:2397\u20132405","journal-title":"Osteoporos Int"},{"key":"6462_CR5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","volume":"36","author":"P Evenepoel","year":"2021","unstructured":"Evenepoel P, Cunningham J, Ferrari S, Haarhaus M, Javaid MK, Lafage-Proust MH, Prieto-Alhambra D, Torres PU, Cannata-Andia J (2021) European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4\u2013G5D. Nephrol Dial Transplant 36:42\u201359","journal-title":"Nephrol Dial Transplant"},{"key":"6462_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1681\/ASN.2010121253","volume":"23","author":"HH Malluche","year":"2012","unstructured":"Malluche HH, Porter DS, Monier-Faugere MC, Mawad H, Pienkowski D (2012) Differences in bone quality in low- and high-turnover renal osteodystrophy. J Am Soc Nephrol 23:525\u2013532","journal-title":"J Am Soc Nephrol"},{"key":"6462_CR7","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"Jadoul M, Albert J, Tyc A, Akizawa T, Arab L, Bragg-Gresham J, Mason N, Prutz K-G, Young E, Pisoni R (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 70:1358\u20131366","journal-title":"Kidney Int"},{"key":"6462_CR8","first-page":"458","volume":"18","author":"M Rodriguez Garcia","year":"2005","unstructured":"Rodriguez Garcia M, Naves Diaz M, Cannata Andia JB (2005) Bone metabolism, vascular calcifications and mortality: associations beyond mere coincidence. J Nephrol 18:458\u2013463","journal-title":"J Nephrol"},{"key":"6462_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/kisup.2013.93","volume":"3","author":"JJ Kazama","year":"2013","unstructured":"Kazama JJ, Iwasaki Y, Fukagawa M (2013) Uremic osteoporosis. Kidney Int Suppl 3:446\u2013450","journal-title":"Kidney Int Suppl"},{"key":"6462_CR10","doi-asserted-by":"crossref","unstructured":"Neto R, Pereira L, Magalh\u00e3es J, Quelhas-Santos J, Martins S, Carvalho C, Fraz\u00e3o JM (2021) Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4. Clin Kidney J","DOI":"10.1093\/ckj\/sfab081"},{"key":"6462_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s40620-017-0406-x","volume":"30","author":"S Yamamoto","year":"2017","unstructured":"Yamamoto S, Fukagawa M (2017) Uremic Toxicity and Bone in CKD. J Nephrol 30:623\u2013627","journal-title":"J Nephrol"},{"key":"6462_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00198-014-2970-4","volume":"26","author":"DB Burr","year":"2015","unstructured":"Burr DB (2015) The complex relationship between bone remodeling and the physical and material properties of bone. Osteoporos Int: J Established Result Coop Between Eur Foundation Osteoporos Natl Osteoporos Foundation USA 26:845\u2013847","journal-title":"Osteoporos Int: J Established Result Coop Between Eur Foundation Osteoporos Natl Osteoporos Foundation USA"},{"key":"6462_CR13","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4103\/1319-2442.206439","volume":"28","author":"MS Najar","year":"2017","unstructured":"Najar MS, Mir MM, Muzamil M (2017) Prevalence of osteoporosis in patients with chronic kidney disease (stages 3\u20135) in comparison with age-and sex-matched controls: A study from Kashmir Valley Tertiary Care Center. Saudi J Kidney Dis Transplant 28:538","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"6462_CR14","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3109\/0886022X.2013.815102","volume":"35","author":"H Aggarwal","year":"2013","unstructured":"Aggarwal H, Jain D, Yadav S, Kaverappa V (2013) Bone mineral density in patients with predialysis chronic kidney disease. Ren Fail 35:1105\u20131111","journal-title":"Ren Fail"},{"key":"6462_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2474-10-60","volume":"10","author":"GS Huang","year":"2009","unstructured":"Huang GS, Chu TS, Lou MF, Hwang SL, Yang RS (2009) Factors associated with low bone mass in the hemodialysis patients\u2013a cross-sectional correlation study. BMC Musculoskelet Disord 10:60","journal-title":"BMC Musculoskelet Disord"},{"key":"6462_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jbm4.10067","volume":"3","author":"A Sidib\u00e9","year":"2019","unstructured":"Sidib\u00e9 A, Auguste D, Desbiens LC, Fortier C, Wang YP, Jean S, Moore L, Mac-Way F (2019) Fracture risk in dialysis and kidney transplanted patients: a systematic review. JBMR plus 3:45\u201355","journal-title":"JBMR plus"},{"key":"6462_CR17","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","volume":"69","author":"FC Barreto","year":"2006","unstructured":"Barreto FC, Barreto DV, Moyses RMA, Neves CL, Jorgetti V, Draibe SA, Canziani ME, Carvalho AB (2006) Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem. Kidney Int 69:1852\u20131857","journal-title":"Kidney Int"},{"key":"6462_CR18","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1681\/ASN.2009121208","volume":"21","author":"TL Nickolas","year":"2010","unstructured":"Nickolas TL, Stein E, Cohen A, Thomas V, Staron RB, McMahon DJ, Leonard MB, Shane E (2010) Bone mass and microarchitecture in CKD patients with fracture. J Am Soc Nephrol 21:1371\u20131380","journal-title":"J Am Soc Nephrol"},{"key":"6462_CR19","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jbmr.309","volume":"26","author":"HH Malluche","year":"2011","unstructured":"Malluche HH, Mawad HW, Monier-Faugere M-C (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res: Off J Am Soc Bone Miner Res 26:1368\u20131376","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1001\/archinte.167.2.133","volume":"167","author":"KE Ensrud","year":"2007","unstructured":"Ensrud KE, Lui L-Y, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133\u2013139","journal-title":"Arch Intern Med"},{"key":"6462_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1681\/ASN.2006050546","volume":"18","author":"LF Fried","year":"2007","unstructured":"Fried LF, Biggs ML, Shlipak MG, Seliger S, Kestenbaum B, Stehman-Breen C, Sarnak M, Siscovick D, Harris T, Cauley J (2007) Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol 18:282\u2013286","journal-title":"J Am Soc Nephrol"},{"key":"6462_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","volume":"44","author":"A Mittalhenkle","year":"2004","unstructured":"Mittalhenkle A, Gillen DL, Stehman-Breen CO (2004) Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis 44:672\u2013679","journal-title":"Am J Kidney Dis"},{"key":"6462_CR23","doi-asserted-by":"crossref","unstructured":"Kini U, Nandeesh B (2012) Physiology of bone formation, remodeling, and metabolism. Radionuclide and hybrid bone imaging. Springer, 29\u201357","DOI":"10.1007\/978-3-642-02400-9_2"},{"key":"6462_CR24","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2106\/00004623-199508000-00019","volume":"77","author":"J Buckwalter","year":"1995","unstructured":"Buckwalter J, Glimcher M, Cooper R, Recker R (1995) Bone biology. J Bone Joint Surg Am 77:1256\u20131275","journal-title":"J Bone Joint Surg Am"},{"key":"6462_CR25","unstructured":"Einhorn T (1996) The bone organ system: form and function. Osteoporosis 3\u201322"},{"key":"6462_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/nep.13457","volume":"23","author":"YC Hou","year":"2018","unstructured":"Hou YC, Lu CL, Lu KC (2018) Mineral bone disorders in chronic kidney disease. Nephrology 23:88\u201394","journal-title":"Nephrology"},{"key":"6462_CR27","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1093\/ndt\/14.8.1922","volume":"14","author":"MW Taal","year":"1999","unstructured":"Taal MW, Masud T, Green D, Cassidy MJ (1999) Risk factors for reduced bone density in haemodialysis patients. Nephrol Dial Transplant 14:1922\u20131928","journal-title":"Nephrol Dial Transplant"},{"key":"6462_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-physiol-021119-034650","volume":"82","author":"J Musgrove","year":"2020","unstructured":"Musgrove J, Wolf M (2020) Regulation and Effects of FGF23 in Chronic Kidney Disease. Annu Rev Physiol 82:365\u2013390","journal-title":"Annu Rev Physiol"},{"key":"6462_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2337\/diaspect.21.1.19","volume":"21","author":"S Tomasello","year":"2008","unstructured":"Tomasello S (2008) Secondary hyperparathyroidism and chronic kidney disease. Diabetes Spectrum 21:19\u201325","journal-title":"Diabetes Spectrum"},{"key":"6462_CR30","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1172\/JCI118224","volume":"96","author":"T Naveh-Many","year":"1995","unstructured":"Naveh-Many T, Rahamimov R, Livni N, Silver J (1995) Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Investig 96:1786\u20131793","journal-title":"J Clin Investig"},{"key":"6462_CR31","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1046\/j.1523-1755.2001.00027.x","volume":"60","author":"CS Ritter","year":"2001","unstructured":"Ritter CS, Finch JL, Slatopolsky EA, Brown AJ (2001) Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney Int 60:1737\u20131744","journal-title":"Kidney Int"},{"key":"6462_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.156","volume":"88","author":"P Evenepoel","year":"2015","unstructured":"Evenepoel P, D\u2019haese P, Brandenburg V (2015) Sclerostin and DKK1: new players in renal bone and vascular disease. Kidney Int 88:235\u2013240","journal-title":"Kidney Int"},{"key":"6462_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s001090100226","volume":"79","author":"LC Hofbauer","year":"2001","unstructured":"Hofbauer LC, Heufelder AE (2001) Role of receptor activator of nuclear factor-\u03baB ligand and osteoprotegerin in bone cell biology. J Mol Med 79:243\u2013253","journal-title":"J Mol Med"},{"key":"6462_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.5414\/CN109650","volume":"91","author":"F Lima","year":"2019","unstructured":"Lima F, Mawad H, El-Husseini AA, Davenport DL, Malluche HH (2019) Serum bone markers in ROD patients across the spectrum of decreases in GFR: activin A increases before all other markers. Clin Nephrol 91:222","journal-title":"Clin Nephrol"},{"key":"6462_CR35","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/jbmr.1644","volume":"27","author":"RM Jacques","year":"2012","unstructured":"Jacques RM, Boonen S, Cosman F, Reid IR, Bauer DC, Black DM, Eastell R (2012) Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res: Off J Am Soc Bone Miner Res 27:1627\u20131634","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR36","unstructured":"Group KDIGOC-MW (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Supplement S1-S130"},{"key":"6462_CR37","doi-asserted-by":"crossref","unstructured":"Ketteler M, Block GA, Evenepoel P et al (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters. Kidney\u00a0Int 92:26\u201336. Kidney Int 92:1558","DOI":"10.1016\/j.kint.2017.10.001"},{"key":"6462_CR38","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2215\/CJN.12871211","volume":"7","author":"RH Yenchek","year":"2012","unstructured":"Yenchek RH, Ix JH, Shlipak MG, Bauer DC, Rianon NJ, Kritchevsky SB, Harris TB, Newman AB, Cauley JA, Fried LF (2012) Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 7:1130\u20131136","journal-title":"Clin J Am Soc Nephrol"},{"key":"6462_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000515534","volume":"7","author":"K Asadipooya","year":"2021","unstructured":"Asadipooya K, Abdalbary M, Ahmad Y, Kakani E, Monier-Faugere MC, El-Husseini A (2021) Bone Quality in CKD Patients: Current Concepts and Future Directions \u2013 Part I. Kidney Dis 7:268\u2013277","journal-title":"Kidney Dis"},{"key":"6462_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int: J Established Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 30:3\u201344","journal-title":"Osteoporos Int: J Established Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6462_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.afos.2019.12.002","volume":"5","author":"S Lekamwasam","year":"2019","unstructured":"Lekamwasam S (2019) The diversity of Fracture Risk Assessment Tool (FRAX)-based intervention thresholds in Asia. Osteoporos Sarcopenia 5:104\u2013108","journal-title":"Osteoporos Sarcopenia"},{"key":"6462_CR42","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jbmr.556","volume":"27","author":"LM Giangregorio","year":"2012","unstructured":"Giangregorio LM, Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA (2012) FRAX underestimates fracture risk in patients with diabetes. J Bone Miner Res: Off J Am Soc Bone Miner Res 27:301\u2013308","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR43","first-page":"57","volume":"30","author":"B Piraino","year":"1988","unstructured":"Piraino B, Chen T, Cooperstein L, Segre G, Puschett J (1988) Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30:57\u201362","journal-title":"Clin Nephrol"},{"key":"6462_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0002-9629(15)40516-6","volume":"317","author":"K Sakhaee","year":"1999","unstructured":"Sakhaee K, Gonzalez GB (1999) Update on renal osteodystrophy: pathogenesis and clinical management. Am J Med Sci 317:251\u2013260","journal-title":"Am J Med Sci"},{"key":"6462_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00198-013-2524-1","volume":"25","author":"SA Jamal","year":"2014","unstructured":"Jamal SA, West SL, Nickolas TL (2014) The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease. Osteoporos Int 25:71\u201376","journal-title":"Osteoporos Int"},{"key":"6462_CR46","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2215\/CJN.06040614","volume":"10","author":"KL Naylor","year":"2015","unstructured":"Naylor KL, Garg AX, Zou G et al (2015) Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol: CJASN 10:646\u2013653","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"6462_CR47","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.kint.2018.09.022","volume":"95","author":"RH Whitlock","year":"2019","unstructured":"Whitlock RH, Leslie WD, Shaw J, Rigatto C, Thorlacius L, Komenda P, Collister D, Kanis JA, Tangri N (2019) The Fracture Risk Assessment Tool (FRAX\u00ae) predicts fracture risk in patients with chronic kidney disease. Kidney Int 95:447\u2013454","journal-title":"Kidney Int"},{"key":"6462_CR48","first-page":"153","volume":"66","author":"T Tseng","year":"2014","unstructured":"Tseng T, Mu C, Hsu C (2014) The correlation between renal function and bone mineral density. Minerva Urol Nefrol 66:153\u2013156","journal-title":"Minerva Urol Nefrol"},{"key":"6462_CR49","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s00198-020-05458-1","volume":"31","author":"C Rampersad","year":"2020","unstructured":"Rampersad C, Whitlock RH, Leslie WD, Rigatto C, Komenda P, Bohm C, Hans D, Tangri N (2020) Trabecular bone score in patients with chronic kidney disease. Osteoporos Int: J Established Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 31:1905\u20131912","journal-title":"Osteoporos Int: J Established Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6462_CR50","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00198-018-4468-y","volume":"29","author":"J Aleksova","year":"2018","unstructured":"Aleksova J, Kurniawan S, Elder GJ (2018) The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease. Osteoporos Int 29:1447\u20131455","journal-title":"Osteoporos Int"},{"key":"6462_CR51","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.00720116","volume":"11","author":"KL Naylor","year":"2016","unstructured":"Naylor KL, Prior J, Garg AX, Berger C, Langsetmo L, Adachi JD, Goltzman D, Kovacs CS, Josse RG, Leslie WD (2016) Trabecular Bone Score and Incident Fragility Fracture Risk in Adults with Reduced Kidney Function. Clin J Am Soc Nephrol: CJASN 11:2032\u20132040","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"6462_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bone.2018.08.006","volume":"116","author":"J Ramalho","year":"2018","unstructured":"Ramalho J, Marques IDB, Hans D, Dempster D, Zhou H, Patel P, Pereira RMR, Jorgetti V, Moyses RMA, Nickolas TL (2018) The trabecular bone score: Relationships with trabecular and cortical microarchitecture measured by HR-pQCT and histomorphometry in patients with chronic kidney disease. Bone 116:215\u2013220","journal-title":"Bone"},{"key":"6462_CR53","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00198-012-2155-y","volume":"24","author":"MA Krieg","year":"2013","unstructured":"Krieg MA, Aubry-Rozier B, Hans D, Leslie WD, Manitoba Bone Density P (2013) Effects of anti-resorptive agents on trabecular bone score (TBS) in older women. Osteoporos Int: J Established Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA 24:1073\u20131078","journal-title":"Osteoporos Int: J Established Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6462_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bone.2014.06.034","volume":"67","author":"WD Leslie","year":"2014","unstructured":"Leslie WD, Aubry-Rozier B, Lix LM, Morin SN, Majumdar SR, Hans D (2014) Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program. Bone 67:10\u201314","journal-title":"Bone"},{"key":"6462_CR55","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00198-014-2761-y","volume":"25","author":"WD Leslie","year":"2014","unstructured":"Leslie WD, Johansson H, Kanis JA, Lamy O, Oden A, McCloskey EV, Hans D (2014) Lumbar spine texture enhances 10-year fracture probability assessment. Osteoporos Int 25:2271\u20132277","journal-title":"Osteoporos Int"},{"key":"6462_CR56","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jbmr.2734","volume":"31","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Od\u00e9n A, Harvey NC et al (2016) A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX. J Bone Miner Res 31:940\u2013948","journal-title":"J Bone Miner Res"},{"key":"6462_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00223-013-9722-x","volume":"93","author":"M Fusaro","year":"2013","unstructured":"Fusaro M, Tripepi G, Noale M et al (2013) High prevalence of vertebral fractures assessed by quantitative morphometry in hemodialysis patients, strongly associated with vascular calcifications. Calcif Tissue Int 93:39\u201347","journal-title":"Calcif Tissue Int"},{"key":"6462_CR58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00198-020-05804-3","volume":"32","author":"WF Lems","year":"2021","unstructured":"Lems WF, Paccou J, Zhang J, Fuggle NR, Chandran M, Harvey NC, Cooper C, Javaid K, Ferrari S, Akesson KE (2021) Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services. Osteoporos Int 32:399\u2013411","journal-title":"Osteoporos Int"},{"key":"6462_CR59","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1385\/JCD:3:3:281","volume":"3","author":"HK Genant","year":"2000","unstructured":"Genant HK, Li J, Wu CY, Shepherd JA (2000) Vertebral fractures in osteoporosis: a new method for clinical assessment. J Clin Densitom 3:281\u2013290","journal-title":"J Clin Densitom"},{"key":"6462_CR60","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician\u2019s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int 25:2359\u20132381","journal-title":"Osteoporos Int"},{"key":"6462_CR61","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1385\/JCD:8:3:362","volume":"8","author":"F Duboeuf","year":"2005","unstructured":"Duboeuf F, Bauer DC, Chapurlat RD, Dinten JM, Delmas P (2005) Assessment of vertebral fracture using densitometric morphometry. J Clin Densitom 8:362\u2013368","journal-title":"J Clin Densitom"},{"key":"6462_CR62","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00198-016-3532-8","volume":"27","author":"L Deleskog","year":"2016","unstructured":"Deleskog L, Laursen N, Nielsen BR, Schwarz P (2016) Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis. Osteoporos Int 27:2317\u20132326","journal-title":"Osteoporos Int"},{"key":"6462_CR63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11914-009-0017-0","volume":"7","author":"MS van Brussel","year":"2009","unstructured":"van Brussel MS, Lems WF (2009) Clinical relevance of diagnosing vertebral fractures by vertebral fracture assessment. Curr Osteoporos Rep 7:103\u2013106","journal-title":"Curr Osteoporos Rep"},{"key":"6462_CR64","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruy\u00e8re O et al (2011) Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391\u2013420","journal-title":"Osteoporos Int"},{"key":"6462_CR65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11914-005-0018-6","volume":"3","author":"PD Miller","year":"2005","unstructured":"Miller PD (2005) Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction. Curr Osteoporos Rep 3:103\u2013110","journal-title":"Curr Osteoporos Rep"},{"key":"6462_CR66","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s00198-017-4082-4","volume":"28","author":"P Szulc","year":"2017","unstructured":"Szulc P, Naylor K, Hoyle NR, Eastell R, Leary ET (2017) Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability. Osteoporos Int 28:2541\u20132556","journal-title":"Osteoporos Int"},{"key":"6462_CR67","doi-asserted-by":"crossref","unstructured":"Tridimas A, Milan A, Marks E (2021) Assessing bone formation in patients with chronic kidney disease using procollagen type I N-terminal propeptide (PINP): The choice of assay makes a difference. Ann Clin Biochem 45632211025567","DOI":"10.1177\/00045632211025567"},{"key":"6462_CR68","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V et al (2016) Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis. Am J Kidney Dis 67:559\u2013566","journal-title":"Am J Kidney Dis"},{"key":"6462_CR69","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","volume":"60","author":"MC Monier-Faugere","year":"2001","unstructured":"Monier-Faugere MC, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, Malluche HH (2001) Improved assessment of bone turnover by the PTH-(1\u201384)\/large C-PTH fragments ratio in ESRD patients. Kidney Int 60:1460\u20131468","journal-title":"Kidney Int"},{"key":"6462_CR70","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1681\/ASN.V73506","volume":"7","author":"P Urena","year":"1996","unstructured":"Urena P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC (1996) Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 7:506\u2013512","journal-title":"J Am Soc Nephrol"},{"key":"6462_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/nep.13593","volume":"25","author":"S Laowalert","year":"2020","unstructured":"Laowalert S, Khotavivattana T, Wattanachanya L, Luangjarmekorn P, Udomkarnjananun S, Katavetin P, Eiam-Ong S, Praditpornsilpa K, Susantitaphong P (2020) Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients. Nephrology (Carlton) 25:163\u2013171","journal-title":"Nephrology (Carlton)"},{"key":"6462_CR72","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto FC, Barreto DV, Moys\u00e9s RM, Neves KR, Canziani ME, Draibe SA, Jorgetti V, Carvalho AB (2008) K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73:771\u2013777","journal-title":"Kidney Int"},{"key":"6462_CR73","doi-asserted-by":"crossref","unstructured":"J\u00f8rgensen HS, Behets G, Viaene L et al (2021) Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy. Am J Kidney Dis","DOI":"10.1093\/ndt\/gfab123.001"},{"key":"6462_CR74","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jbmr.3471","volume":"33","author":"CJ Crandall","year":"2018","unstructured":"Crandall CJ, Vasan S, LaCroix A, LeBoff MS, Cauley JA, Robbins JA, Jackson RD, Bauer DC (2018) Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women\u2019s Health Initiative. J Bone Miner Res 33:1199\u20131208","journal-title":"J Bone Miner Res"},{"key":"6462_CR75","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12882-017-0692-5","volume":"18","author":"HS J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen HS, Winther S, B\u00f8ttcher M, Hauge EM, Rejnmark L, Svensson M, Ivarsen P (2017) Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. BMC Nephrol 18:284","journal-title":"BMC Nephrol"},{"key":"6462_CR76","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1681\/ASN.2010121275","volume":"22","author":"TL Nickolas","year":"2011","unstructured":"Nickolas TL, Cremers S, Zhang A, Thomas V, Stein E, Cohen A, Chauncey R, Nikkel L, Yin MT, Liu XS (2011) Discriminants of prevalent fractures in chronic kidney disease. J Am Soc Nephrol 22:1560\u20131572","journal-title":"J Am Soc Nephrol"},{"key":"6462_CR77","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","volume":"29","author":"Y Maruyama","year":"2014","unstructured":"Maruyama Y, Taniguchi M, Kazama JJ, Yokoyama K, Hosoya T, Yokoo T, Shigematsu T, Iseki K, Tsubakihara Y (2014) A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan. Nephrol Dial Transplant 29:1532\u20131538","journal-title":"Nephrol Dial Transplant"},{"key":"6462_CR78","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ndt\/gfr317","volume":"27","author":"S Iimori","year":"2012","unstructured":"Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T, Kuwahara M, Sasaki S, Tsukamoto Y (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2013a single-center cohort study. Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc- Eur Renal Assoc 27:345\u2013351","journal-title":"Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc- Eur Renal Assoc"},{"key":"6462_CR79","doi-asserted-by":"crossref","DOI":"10.1159\/isbn.978-3-318-04339-6","volume-title":"Atlas of Mineralized Bone Histology","author":"HH Malluche","year":"1986","unstructured":"Malluche HH, Faugere MC (1986) Atlas of Mineralized Bone Histology. Karger, New York"},{"key":"6462_CR80","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","volume":"89","author":"TB Dr\u00fceke","year":"2016","unstructured":"Dr\u00fceke TB, Massy ZA (2016) Changing bone patterns with progression of chronic kidney disease. Kidney Int 89:289\u2013302","journal-title":"Kidney Int"},{"key":"6462_CR81","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00198-004-1805-0","volume":"16","author":"J Kanis","year":"2005","unstructured":"Kanis J, Johnell O, Od\u00e9n A, De Laet C, De Terlizzi F (2005) Ten-year probabilities of clinical vertebral fractures according to phalangeal quantitative ultrasonography. Osteoporos Int 16:1065\u20131070","journal-title":"Osteoporos Int"},{"key":"6462_CR82","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.rcl.2010.02.013","volume":"48","author":"G Guglielmi","year":"2010","unstructured":"Guglielmi G, Scalzo G, de Terlizzi F, Peh WC (2010) Quantitative ultrasound in osteoporosis and bone metabolism pathologies. Radiologic Clinics 48:577\u2013588","journal-title":"Radiologic Clinics"},{"key":"6462_CR83","doi-asserted-by":"publisher","first-page":"044301","DOI":"10.1063\/1.3693085","volume":"83","author":"D Bridges","year":"2012","unstructured":"Bridges D, Randall C, Hansma PK (2012) A new device for performing reference point indentation without a reference probe. Rev Sci Instrum 83:044301","journal-title":"Rev Sci Instrum"},{"key":"6462_CR84","doi-asserted-by":"crossref","unstructured":"Randall C, Bridges D, Guerri R, Nogues X, Puig L, Torres E, Mellibovsky L, Hoffseth K, Stalbaum T, Srikanth A (2013) Applications of a new handheld reference point indentation instrument measuring bone material strength. J Med Devices 7:","DOI":"10.1115\/1.4024829"},{"key":"6462_CR85","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jbmr.1731","volume":"28","author":"RC G\u00fcerri-Fern\u00e1ndez","year":"2013","unstructured":"G\u00fcerri-Fern\u00e1ndez RC, Nogu\u00e9s X, Quesada G\u00f3mez JM, Torres del Pliego E, Puig L, Garc\u00eda-Giralt N, Yoskovitz G, Mellibovsky L, Hansma PK, D\u00edez-P\u00e9rez A (2013) Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls. J Bone Miner Res 28:162\u2013168","journal-title":"J Bone Miner Res"},{"key":"6462_CR86","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fendo.2020.00015","volume":"11","author":"M Schoeb","year":"2020","unstructured":"Schoeb M, Hamdy NAT, Malgo F, Winter EM, Appelman-Dijkstra NM (2020) Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature. Front Endocrinol (Lausanne) 11:15","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6462_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115241","volume":"133","author":"KL Holloway-Kew","year":"2020","unstructured":"Holloway-Kew KL, Rufus-Membere P, Anderson KB, Betson A, Gaston J, Kotowicz MA, Diez-Perez A, Hyde NK, Pasco JA (2020) Bone material strength index is associated with prior fracture in men with and without moderate chronic kidney disease. Bone 133:115241","journal-title":"Bone"},{"key":"6462_CR88","doi-asserted-by":"crossref","unstructured":"Asadipooya K, Abdalbary M, Ahmad Y, Kakani E, Monier-Faugere M-C, El-Husseini A (2021) Bone Quality in Chronic Kidney Disease Patients: Current Concepts and Future Directions\u2013Part II. Kidney Dis 1\u201313","DOI":"10.1159\/000515542"},{"key":"6462_CR89","doi-asserted-by":"crossref","unstructured":"Rysz J, Franczyk B, Rokicki R, Gluba-Brz\u00f3zka A (2021) The Influence of Dietary Interventions on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Nutrients 13:","DOI":"10.3390\/nu13062065"},{"key":"6462_CR90","first-page":"1397","volume":"36","author":"R Krause","year":"2016","unstructured":"Krause R, Roth HJ, Kaase H, Stange R, Holick MF (2016) Vitamin D Status in Chronic Kidney Disease - UVB Irradiation Is Superior to Oral Supplementation. Anticancer Res 36:1397\u20131401","journal-title":"Anticancer Res"},{"key":"6462_CR91","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1111\/j.1523-1755.2005.00603.x","volume":"68","author":"G Coen","year":"2005","unstructured":"Coen G, Mantella D, Manni M, Balducci A, Nofroni I, Sardella D, Ballanti P, Bonucci E (2005) 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. Kidney Int 68:1840\u20131848","journal-title":"Kidney Int"},{"key":"6462_CR92","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12882-020-01999-z","volume":"21","author":"DF Cardoso","year":"2020","unstructured":"Cardoso DF, Marques EA, Leal DV, Ferreira A, Baker LA, Smith AC, Viana JL (2020) Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies. BMC Nephrol 21:334\u2013334","journal-title":"BMC Nephrol"},{"key":"6462_CR93","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s00223-019-00606-0","volume":"105","author":"S Yuan","year":"2019","unstructured":"Yuan S, Micha\u00eblsson K, Wan Z, Larsson SC (2019) Associations of Smoking and Alcohol and Coffee Intake with Fracture and Bone Mineral Density: A Mendelian Randomization Study. Calcif Tissue Int 105:582\u2013588","journal-title":"Calcif Tissue Int"},{"key":"6462_CR94","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1440-1797.2010.01412.x","volume":"16","author":"ND Toussaint","year":"2011","unstructured":"Toussaint ND, Lau KK, Polkinghorne KR, Kerr PG (2011) Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial. Nephrology (Carlton) 16:290\u2013298","journal-title":"Nephrology (Carlton)"},{"key":"6462_CR95","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","volume":"26","author":"P Raggi","year":"2011","unstructured":"Raggi P, Chertow GM, Torres PU et al (2011) The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant 26:1327\u20131339","journal-title":"Nephrol Dial Transplant"},{"key":"6462_CR96","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","volume":"15","author":"GM London","year":"2004","unstructured":"London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943\u20131951","journal-title":"J Am Soc Nephrol"},{"key":"6462_CR97","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ki.2014.349","volume":"87","author":"GJ Behets","year":"2015","unstructured":"Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, D\u2019Haese PC (2015) Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int 87:846\u2013856","journal-title":"Kidney Int"},{"key":"6462_CR98","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.kint.2018.12.015","volume":"95","author":"JM Diaz-Tocados","year":"2019","unstructured":"Diaz-Tocados JM, Rodriguez-Ortiz ME, Almaden Y et al (2019) Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone concentration. Kidney Int 95:1064\u20131078","journal-title":"Kidney Int"},{"key":"6462_CR99","doi-asserted-by":"crossref","unstructured":"Jean G, Souberbielle JC, Chazot C (2017) Vitamin D in Chronic Kidney Disease and Dialysis Patients. Nutrients 9:","DOI":"10.3390\/nu9040328"},{"key":"6462_CR100","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00223-021-00844-1","volume":"109","author":"M Christodoulou","year":"2021","unstructured":"Christodoulou M, Aspray TJ, Schoenmakers I (2021) Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines. Calcif Tissue Int 109:157\u2013178","journal-title":"Calcif Tissue Int"},{"key":"6462_CR101","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1210\/clinem\/dgaa851","volume":"106","author":"A Broadwell","year":"2021","unstructured":"Broadwell A, Chines A, Ebeling PR, Franek E, Huang S, Smith S, Kendler D, Messina O, Miller PD (2021) Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease. J Clin Endocrinol Metab 106:397\u2013409","journal-title":"J Clin Endocrinol Metab"},{"key":"6462_CR102","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/jbmr.403","volume":"26","author":"SA Jamal","year":"2011","unstructured":"Jamal SA, Ljunggren O, Stehman-Breen C et al (2011) Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res: Off J Am Soc Bone Miner Res 26:1829\u20131835","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR103","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10067-016-3447-y","volume":"36","author":"BC Cheng","year":"2017","unstructured":"Cheng BC, Chen YC (2017) Young patients and those with a low eGFR benefitted more from denosumab therapy in femoral neck bone mineral density. Clin Rheumatol 36:929\u2013932","journal-title":"Clin Rheumatol"},{"key":"6462_CR104","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1210\/jc.2014-1154","volume":"99","author":"CL Chen","year":"2014","unstructured":"Chen CL, Chen NC, Hsu CY, Chou KJ, Lee PT, Fang HC, Renn JH (2014) An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis. J Clin Endocrinol Metab 99:2426\u20132432","journal-title":"J Clin Endocrinol Metab"},{"key":"6462_CR105","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1210\/jc.2015-1259","volume":"100","author":"CL Chen","year":"2015","unstructured":"Chen CL, Chen NC, Liang HL, Hsu CY, Chou KJ, Fang HC, Lee PT (2015) Effects of Denosumab and Calcitriol on Severe Secondary Hyperparathyroidism in Dialysis Patients With Low Bone Mass. J Clin Endocrinol Metab 100:2784\u20132792","journal-title":"J Clin Endocrinol Metab"},{"key":"6462_CR106","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00198-018-4533-6","volume":"29","author":"C Thongprayoon","year":"2018","unstructured":"Thongprayoon C, Acharya P, Acharya C et al (2018) Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 29:1737\u20131745","journal-title":"Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6462_CR107","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1038\/s41598-020-59143-8","volume":"10","author":"K Kunizawa","year":"2020","unstructured":"Kunizawa K, Hiramatsu R, Hoshino J et al (2020) Denosumab for dialysis patients with osteoporosis: A cohort study. Sci Rep 10:2496","journal-title":"Sci Rep"},{"key":"6462_CR108","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/jbmr.3676","volume":"34","author":"K Iseri","year":"2019","unstructured":"Iseri K, Watanabe M, Yoshikawa H, Mitsui H, Endo T, Yamamoto Y, Iyoda M, Ryu K, Inaba T, Shibata T (2019) Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial. J Bone Miner Res: Off J Am Soc Bone Miner Res 34:1014\u20131024","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR109","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/ndt\/gfaa359","volume":"36","author":"R Hiramatsu","year":"2021","unstructured":"Hiramatsu R, Ubara Y, Sawa N, Sakai A (2021) Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study. Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc-Eur Renal Assoc 36:1900\u20131907","journal-title":"Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc-Eur Renal Assoc"},{"key":"6462_CR110","doi-asserted-by":"publisher","first-page":"6218129","DOI":"10.1155\/2017\/6218129","volume":"2017","author":"H Takami","year":"2017","unstructured":"Takami H, Washio K, Gotoh H (2017) Denosumab for Male Hemodialysis Patients with Low Bone Mineral Density: A Case-Control Study. Int J Nephrol 2017:6218129","journal-title":"Int J Nephrol"},{"key":"6462_CR111","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1053\/j.ajkd.2015.03.012","volume":"66","author":"R Hiramatsu","year":"2015","unstructured":"Hiramatsu R, Ubara Y, Sawa N et al (2015) Denosumab for low bone mass in hemodialysis patients: a noncontrolled trial. Am J Kidney Dis 66:175\u2013177","journal-title":"Am J Kidney Dis"},{"key":"6462_CR112","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/jbmr.1613","volume":"27","author":"GA Block","year":"2012","unstructured":"Block GA, Bone HG, Fang L, Lee E, Padhi D (2012) A single-dose study of denosumab in patients with various degrees of renal impairment. J Bone Miner Res: Off J Am Soc Bone Miner Res 27:1471\u20131479","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR113","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40620-016-0334-1","volume":"30","author":"F Festuccia","year":"2017","unstructured":"Festuccia F, Jafari MT, Moioli A, Fofi C, Barberi S, Amendola S, Sciacchitano S, Punzo G, Men\u00e8 P (2017) Safety and efficacy of denosumab in osteoporotic hemodialysed patients. J Nephrol 30:271\u2013279","journal-title":"J Nephrol"},{"key":"6462_CR114","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11657-019-0587-0","volume":"14","author":"C Thongprayoon","year":"2019","unstructured":"Thongprayoon C, Acharya P, Aeddula NR et al (2019) Effects of denosumab on bone metabolism and bone mineral density in kidney transplant patients: a systematic review and meta-analysis. Arch Osteoporos 14:35","journal-title":"Arch Osteoporos"},{"key":"6462_CR115","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jbmr.3337","volume":"33","author":"SR Cummings","year":"2018","unstructured":"Cummings SR, Ferrari S, Eastell R et al (2018) Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension. J Bone Miner Res: Off J Am Soc Bone Miner Res 33:190\u2013198","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR116","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.2169\/internalmedicine.54.4946","volume":"54","author":"K Ueki","year":"2015","unstructured":"Ueki K, Yamada S, Tsuchimoto A, Tokumoto M, Kumano T, Kitazono T, Tsuruya K (2015) Rapid progression of vascular and soft tissue calcification while being managed for severe and persistent hypocalcemia induced by denosumab treatment in a patient with multiple myeloma and chronic kidney disease. Internal Med (Tokyo, Japan) 54:2637\u20132642","journal-title":"Internal Med (Tokyo, Japan)"},{"key":"6462_CR117","first-page":"510","volume":"21","author":"R Bergner","year":"2008","unstructured":"Bergner R, Henrich D, Hoffmann M, Schmidt-Gayk H, Lenz T, Upperkamp M (2008) Treatment of reduced bone density with ibandronate in dialysis patients. J Nephrol 21:510\u2013516","journal-title":"J Nephrol"},{"key":"6462_CR118","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/j.ajkd.2009.12.039","volume":"56","author":"ND Toussaint","year":"2010","unstructured":"Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG (2010) Effect of alendronate on vascular calcification in CKD stages 3 and 4: a pilot randomized controlled trial. Am J Kidney Dis 56:57\u201368","journal-title":"Am J Kidney Dis"},{"key":"6462_CR119","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000341864","volume":"36","author":"E Mitsopoulos","year":"2012","unstructured":"Mitsopoulos E, Ginikopoulou E, Economidou D, Zanos S, Pateinakis P, Minasidis E, Memmos D, Thodis E, Vargemezis V, Tsakiris D (2012) Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study. Am J Nephrol 36:238\u2013244","journal-title":"Am J Nephrol"},{"key":"6462_CR120","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1359\/JBMR.050817","volume":"20","author":"PD Miller","year":"2005","unstructured":"Miller PD, Roux C, Boonen S, Barton IP, Dunlap LE, Burgio DE (2005) Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res: Off J Am Soc Bone Miner Res 20:2105\u20132115","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR121","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1359\/jbmr.070112","volume":"22","author":"SA Jamal","year":"2007","unstructured":"Jamal SA, Bauer DC, Ensrud KE, Cauley JA, Hochberg M, Ishani A, Cummings SR (2007) Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res: Off J Am Soc Bone Miner Res 22:503\u2013508","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR122","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12882-017-0478-9","volume":"18","author":"T Shigematsu","year":"2017","unstructured":"Shigematsu T, Muraoka R, Sugimoto T, Nishizawa Y (2017) Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials. BMC Nephrol 18:66","journal-title":"BMC Nephrol"},{"key":"6462_CR123","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/jbmr.2361","volume":"30","author":"R Eastell","year":"2015","unstructured":"Eastell R, Boonen S, Cosman F, Reid IR, Palermo L, Cummings SR, Black DM (2015) Relationship between pretreatment rate of bone loss and bone density response to once-yearly ZOL: HORIZON-PFT extension study. J Bone Miner Res: Off J Am Soc Bone Miner Res 30:570\u2013574","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR124","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000276666","volume":"29","author":"R Amerling","year":"2010","unstructured":"Amerling R, Harbord NB, Pullman J, Feinfeld DA (2010) Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series. Blood Purif 29:293\u2013299","journal-title":"Blood Purif"},{"key":"6462_CR125","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P et al (2017) Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters. Kidney Int 92:26\u201336","journal-title":"Kidney Int"},{"key":"6462_CR126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"KDIGO","year":"2017","unstructured":"KDIGO (2017) Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 7:1\u201359","journal-title":"Kidney Int Suppl"},{"key":"6462_CR127","doi-asserted-by":"crossref","unstructured":"Ma HY, Chen S, Lu LL, Gong W, Zhang AH (2021) Raloxifene in the Treatment of Osteoporosis in Postmenopausal Women with End-Stage Renal Disease: A Systematic Review and Meta-Analysis. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 53:730\u2013737","DOI":"10.1055\/a-1655-4362"},{"key":"6462_CR128","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1046\/j.1523-1755.2003.00005.x","volume":"63","author":"E Hernandez","year":"2003","unstructured":"Hernandez E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR (2003) Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis. Kidney Int 63:2269\u20132274","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"6462_CR129","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1744-9987.2011.00929.x","volume":"15","author":"M Tanaka","year":"2011","unstructured":"Tanaka M, Itoh K, Matsushita K, Matsushita K, Moriishi M, Kawanishi H, Fukagawa M (2011) Effects of raloxifene on bone mineral metabolism in postmenopausal Japanese women on hemodialysis. Ther Apher Dial: Off Peer-Rev J Int Soc Apheresis Jpn Soc Apheresis Jpn Soc Dial Ther 15(Suppl 1):62\u201366","journal-title":"Ther Apher Dial: Off Peer-Rev J Int Soc Apheresis Jpn Soc Apheresis Jpn Soc Dial Ther"},{"key":"6462_CR130","first-page":"461","volume":"8","author":"F Haghverdi","year":"2014","unstructured":"Haghverdi F, Farbodara T, Mortaji S, Soltani P, Saidi N (2014) Effect of raloxifene on parathyroid hormone in osteopenic and osteoporotic postmenopausal women with chronic kidney disease stage 5. Iran J Kidney Dis 8:461\u2013466","journal-title":"Iran J Kidney Dis"},{"key":"6462_CR131","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3109\/13697137.2013.830605","volume":"17","author":"S Adami","year":"2014","unstructured":"Adami S, Palacios S, Rizzoli R, Levine AB, Sutradhar S, Chines AA (2014) The efficacy and safety of bazedoxifene in postmenopausal women by baseline kidney function status. Climacteric\u202f: J Int Menopause Soc 17:273\u2013284","journal-title":"Climacteric : J Int Menopause Soc"},{"key":"6462_CR132","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/1744-9987.12867","volume":"24","author":"J Yamamoto","year":"2020","unstructured":"Yamamoto J, Nakazawa D, Nishio S et al (2020) Impact of Weekly Teriparatide on the Bone and Mineral Metabolism in Hemodialysis Patients With Relatively Low Serum Parathyroid Hormone: A Pilot Study. Ther Apheresis Dial: Off Peer-Rev J Int Soc Apheresis Jpn Soc Apheresis Jpn Soc Dial Ther 24:146\u2013153","journal-title":"Ther Apheresis Dial: Off Peer-Rev J Int Soc Apheresis Jpn Soc Apheresis Jpn Soc Dial Ther"},{"key":"6462_CR133","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1053\/j.ajkd.2015.01.025","volume":"65","author":"P Palcu","year":"2015","unstructured":"Palcu P, Dion N, Ste-Marie LG, Goltzman D, Radziunas I, Miller PD, Jamal SA (2015) Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report. Am J Kidney Dis 65:933\u2013936","journal-title":"Am J Kidney Dis"},{"key":"6462_CR134","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00198-015-3377-6","volume":"27","author":"K Sumida","year":"2016","unstructured":"Sumida K, Ubara Y, Hoshino J et al (2016) Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 27:1441\u20131450","journal-title":"Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6462_CR135","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000316708","volume":"33","author":"D Cejka","year":"2010","unstructured":"Cejka D, Kodras K, Bader T, Haas M (2010) Treatment of Hemodialysis-Associated Adynamic Bone Disease with Teriparatide (PTH1-34): A Pilot Study. Kidney Blood Press Res 33:221\u2013226","journal-title":"Kidney Blood Press Res"},{"key":"6462_CR136","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","volume":"18","author":"PD Miller","year":"2007","unstructured":"Miller PD, Schwartz EN, Chen P, Misurski DA, Krege JH (2007) Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 18:59\u201368","journal-title":"Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6462_CR137","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1080\/03007995.2019.1656955","volume":"35","author":"JP Bilezikian","year":"2019","unstructured":"Bilezikian JP, Hattersley G, Mitlak BH, Hu MY, Fitzpatrick LA, Dabrowski C, Miller PD, Papapoulos SE (2019) Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial. Curr Med Res Opin 35:2097\u20132102","journal-title":"Curr Med Res Opin"},{"key":"6462_CR138","first-page":"Cd013424","volume":"7","author":"T Hara","year":"2021","unstructured":"Hara T, Hijikata Y, Matsubara Y, Watanabe N (2021) Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3\u20135D. Cochrane Database Syst Rev 7:Cd013424","journal-title":"Cochrane Database Syst Rev"},{"key":"6462_CR139","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","volume":"39","author":"M Sato","year":"2021","unstructured":"Sato M, Inaba M, Yamada S, Emoto M, Ohno Y, Tsujimoto Y (2021) Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study. J Bone Miner Metab 39:1082\u20131090","journal-title":"J Bone Miner Metab"},{"key":"6462_CR140","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ndt\/gfy129","volume":"34","author":"VM Brandenburg","year":"2019","unstructured":"Brandenburg VM, Verhulst A, Babler A, D\u2019Haese PC, Evenepoel P, Kaesler N (2019) Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it! Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc-Eur Renal Assoc 34:408\u2013414","journal-title":"Nephrol Dial Transplant: Off Publ Eur Dial Transplant Assoc-Eur Renal Assoc"},{"key":"6462_CR141","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1161\/ATVBAHA.119.312371","volume":"39","author":"K Asadipooya","year":"2019","unstructured":"Asadipooya K, Weinstock A (2019) Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate. Arterioscler Thromb Vasc Biol 39:1343\u20131350","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6462_CR142","doi-asserted-by":"crossref","unstructured":"Schini M, Peel N, Toronjo-Urquiza L, Thomas E, Salam S, Khwaja A, Eastell R, Walsh JS (2021) Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis. Osteoporos Int: J Established Result Coop Between Eur Found Osteoporos Natl Osteoporos Found USA","DOI":"10.1007\/s00198-021-06160-6"},{"key":"6462_CR143","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/jbmr.4283","volume":"36","author":"P Khairallah","year":"2021","unstructured":"Khairallah P, Nickolas TL (2021) Bisphosphonates in Kidney Disease-Safety First. J Bone Miner Res: Off J Am Soc Bone Miner Res 36:817\u2013819","journal-title":"J Bone Miner Res: Off J Am Soc Bone Miner Res"},{"key":"6462_CR144","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.kint.2021.04.043","volume":"100","author":"M Haarhaus","year":"2021","unstructured":"Haarhaus M, Evenepoel P (2021) Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. Kidney Int 100:546\u2013558","journal-title":"Kidney Int"},{"key":"6462_CR145","doi-asserted-by":"crossref","unstructured":"Lerman DA, Prasad S, Alotti N (2016) Denosumab could be a Potential Inhibitor of Valvular Interstitial Cells Calcification in vitro. Int J Cardiovasc Res 5:","DOI":"10.4172\/2324-8602.1000249"},{"key":"6462_CR146","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","volume":"143","author":"TA Pawade","year":"2021","unstructured":"Pawade TA, Doris MK, Bing R et al (2021) Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial. Circulation 143:2418\u20132427","journal-title":"Circulation"},{"key":"6462_CR147","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jbmr.2043","volume":"29","author":"EJ Samelson","year":"2014","unstructured":"Samelson EJ, Miller PD, Christiansen C et al (2014) RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res 29:450\u2013457","journal-title":"J Bone Miner Res"},{"key":"6462_CR148","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1097\/00029330-200807020-00007","volume":"121","author":"SX Wang","year":"2008","unstructured":"Wang SX, Li H (2008) Salmon calcitonin in prevention of osteoporosis in maintenance dialysis patients. Chin Med J 121:1280\u20131284","journal-title":"Chin Med J"},{"key":"6462_CR149","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ki.2015.315","volume":"89","author":"CL Newman","year":"2016","unstructured":"Newman CL, Creecy A, Granke M et al (2016) Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease. Kidney Int 89:95\u2013104","journal-title":"Kidney Int"},{"key":"6462_CR150","doi-asserted-by":"publisher","first-page":"649","DOI":"10.7326\/M16-2752","volume":"166","author":"LM Wilson","year":"2017","unstructured":"Wilson LM, Rebholz CM, Jirru E, Liu MC, Zhang A, Gayleard J, Chu Y, Robinson KA (2017) Benefits and Harms of Osteoporosis Medications in Patients With Chronic Kidney Disease: A Systematic Review and Meta-analysis. Ann Intern Med 166:649\u2013658","journal-title":"Ann Intern Med"},{"key":"6462_CR151","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s11914-018-0483-3","volume":"16","author":"J Aleksova","year":"2018","unstructured":"Aleksova J, Rodriguez AJ, McLachlan R, Kerr P, Milat F, Ebeling PR (2018) Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: a Systematic Review and Meta-Analysis. Curr Osteoporos Rep 16:674\u2013692","journal-title":"Curr Osteoporos Rep"},{"key":"6462_CR152","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.kint.2021.09.011","volume":"100","author":"A El-Husseini","year":"2021","unstructured":"El-Husseini A, Sobh M, Elshabrawy N, Abdalbary M (2021) Antiresorptives in patients with chronic kidney disease with adynamic bone: Is absence of evidence of harm equal to no harm? Kidney Int 100:1341\u20131342","journal-title":"Kidney Int"},{"key":"6462_CR153","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/annrheumdis-2020-eular.4539","volume":"79","author":"P Miller","year":"2020","unstructured":"Miller P, Adachi J, Albergaria BH et al (2020) OP0297 Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease. Ann Rheum Dis 79:185\u2013185","journal-title":"Ann Rheum Dis"},{"key":"6462_CR154","doi-asserted-by":"crossref","unstructured":"Sato M, Inaba M, Yamada S, Emoto M, Ohno Y, Tsujimoto Y (2021) Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study. J Bone Miner Metab","DOI":"10.1007\/s00774-021-01253-y"},{"key":"6462_CR155","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/jamainternmed.2020.6615","volume":"181","author":"C Salvarani","year":"2021","unstructured":"Salvarani C, Dolci G, Massari M et al (2021) Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial. JAMA Intern Med 181:24\u201331","journal-title":"JAMA Intern Med"},{"key":"6462_CR156","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jama.2021.11330","volume":"326","author":"M Shankar-Hari","year":"2021","unstructured":"Shankar-Hari M, Vale CL, Godolphin PJ et al (2021) Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. JAMA 326:499\u2013518","journal-title":"JAMA"},{"key":"6462_CR157","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/sdi.12833","volume":"32","author":"E Kakani","year":"2019","unstructured":"Kakani E, Sloan D, Sawaya BP, El-Husseini A, Malluche HH, Rao M (2019) Long-term outcomes and management considerations after parathyroidectomy in the dialysis patient. Semin Dial 32:541\u2013552","journal-title":"Semin Dial"},{"key":"6462_CR158","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/01.tp.0000203557.36884.e3","volume":"81","author":"R Marc\u00e9n","year":"2006","unstructured":"Marc\u00e9n R, Caballero C, Pascual J et al (2006) Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study. Transplantation 81:826\u2013831","journal-title":"Transplantation"},{"key":"6462_CR159","doi-asserted-by":"publisher","first-page":"115554","DOI":"10.1016\/j.bone.2020.115554","volume":"140","author":"K Iseri","year":"2020","unstructured":"Iseri K, Carrero JJ, Evans M, Fell\u00e4nder-Tsai L, Berg HE, Runesson B, Stenvinkel P, Lindholm B, Qureshi AR (2020) Fractures after kidney transplantation: Incidence, predictors, and association with mortality. Bone 140:115554","journal-title":"Bone"},{"key":"6462_CR160","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1097\/TP.0b013e3181a6bbda","volume":"87","author":"LE Nikkel","year":"2009","unstructured":"Nikkel LE, Hollenbeak CS, Fox EJ, Uemura T, Ghahramani N (2009) Risk of fractures after renal transplantation in the United States. Transplantation 87:1846\u20131851","journal-title":"Transplantation"},{"key":"6462_CR161","doi-asserted-by":"crossref","unstructured":"J\u00f8rgensen HS, Behets G, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers DRJ, D'Haese P, Evenepoel P (2021) Patterns of renal osteodystrophy one year after kidney transplantation. Nephrol Dial Transplant","DOI":"10.1093\/ndt\/gfab147.003"},{"key":"6462_CR162","doi-asserted-by":"publisher","first-page":"3371","DOI":"10.1016\/j.transproceed.2018.04.032","volume":"50","author":"M Yanishi","year":"2018","unstructured":"Yanishi M, Kinoshita H, Tsukaguchi H, Kimura Y, Koito Y, Sugi M, Matsuda T (2018) Factors Related to Osteosarcopenia in Kidney Transplant Recipients. Transplant Proc 50:3371\u20133375","journal-title":"Transplant Proc"},{"key":"6462_CR163","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00198-019-04906-x","volume":"30","author":"G Adami","year":"2019","unstructured":"Adami G, Saag KG (2019) Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA 30:1145\u20131156","journal-title":"Osteoporos Int: J Established Result Cooperation Between Eur Found Osteoporos Natl Osteoporos Found USA"},{"key":"6462_CR164","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1681\/ASN.2011060623","volume":"23","author":"M Coco","year":"2012","unstructured":"Coco M, Pullman J, Cohen HW, Lee S, Shapiro C, Solorzano C, Greenstein S, Glicklich D (2012) Effect of risedronate on bone in renal transplant recipients. J Am Soc Nephrol 23:1426\u20131437","journal-title":"J Am Soc Nephrol"},{"key":"6462_CR165","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1681\/ASN.2018060656","volume":"30","author":"IDB Marques","year":"2019","unstructured":"Marques IDB, Ara\u00fajo M, Graciolli FG et al (2019) A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation. J Am Soc Nephrol 30:355\u2013365","journal-title":"J Am Soc Nephrol"},{"key":"6462_CR166","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/ndt\/gfaa371","volume":"36","author":"SH Song","year":"2021","unstructured":"Song SH, Choi HY, Kim HY, Nam CM, Jeong HJ, Kim MS, Kim SII, Kim YS, Huh KH, Kim BS (2021) Effects of bisphosphonates on long-term kidney transplantation outcomes. Nephrol Dial Transplant 36:722\u2013729","journal-title":"Nephrol Dial Transplant"},{"key":"6462_CR167","doi-asserted-by":"crossref","unstructured":"Cianciolo G, Tondolo F, Barbuto S, Iacovella F, Zavatta G, Altieri P, Grandinetti V, Comai G, Cozzolino M, La Manna G (2021) Denosumab-Induced Hypocalcemia and Hyperparathyroidism in de novo Kidney Transplant Recipients. Am J Nephrol 1\u20139","DOI":"10.1159\/000518363"},{"key":"6462_CR168","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1097\/TP.0000000000001547","volume":"101","author":"M Bonani","year":"2017","unstructured":"Bonani M, Frey D, de Rougemont O, Mueller NJ, Mueller TF, Graf N, W\u00fcthrich RP (2017) Infections in De Novo Kidney Transplant Recipients Treated With the RANKL Inhibitor Denosumab. Transplantation 101:2139\u20132145","journal-title":"Transplantation"},{"key":"6462_CR169","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1111\/j.1600-6143.2008.02327.x","volume":"8","author":"D Cejka","year":"2008","unstructured":"Cejka D, Benesch T, Krestan C, Roschger P, Klaushofer K, Pietschmann P, Haas M (2008) Effect of teriparatide on early bone loss after kidney transplantation. Am J Transplant 8:1864\u20131870","journal-title":"Am J Transplant"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06462-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-022-06462-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-022-06462-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T14:34:33Z","timestamp":1727447673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-022-06462-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":169,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6462"],"URL":"https:\/\/doi.org\/10.1007\/s00198-022-06462-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742209983.793593838","asserted-by":"object"}]},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"10 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mohamed Abdalbary, Mahmoud Sobh, Sherouk Elnagar, Muhammed A. Elhadedy, Nehal Elshabrawy, Mostafa Abdelsalam, Kamyar Asadipooya, Alaa Sabry, Ahmed Halawa, and Amr El-Husseini have no ethical conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}